Comerica Bank Sells 5,419 Shares of Doximity, Inc. (NASDAQ:DOCS)

Comerica Bank lowered its stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 5.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 92,262 shares of the company's stock after selling 5,419 shares during the period. Comerica Bank's holdings in Doximity were worth $4,926,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Barclays PLC lifted its position in Doximity by 60.5% during the 3rd quarter. Barclays PLC now owns 53,401 shares of the company's stock worth $2,327,000 after acquiring an additional 20,125 shares during the period. Franklin Resources Inc. boosted its position in Doximity by 564.1% in the third quarter. Franklin Resources Inc. now owns 83,098 shares of the company's stock valued at $3,487,000 after buying an additional 70,585 shares during the last quarter. JPMorgan Chase & Co. raised its position in Doximity by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 498,056 shares of the company's stock worth $21,700,000 after buying an additional 15,771 shares during the last quarter. GAMMA Investing LLC raised its position in Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock worth $93,000 after buying an additional 296 shares during the last quarter. Finally, Nordea Investment Management AB lifted its stake in Doximity by 6.2% during the 4th quarter. Nordea Investment Management AB now owns 52,176 shares of the company's stock valued at $2,815,000 after acquiring an additional 3,053 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Doximity

In related news, CFO Anna Bryson sold 45,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the sale, the chief financial officer now owns 357,165 shares in the company, valued at $20,440,552.95. This represents a 11.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $56.93, for a total value of $113,860.00. Following the transaction, the director now owns 16,618 shares in the company, valued at $946,062.74. This represents a 10.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 37.40% of the company's stock.

Doximity Price Performance

DOCS traded down $0.25 on Friday, reaching $59.10. 1,772,024 shares of the company traded hands, compared to its average volume of 2,014,604. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The stock's 50 day moving average price is $58.16 and its 200-day moving average price is $57.03. The company has a market cap of $11.03 billion, a price-to-earnings ratio of 59.10, a PEG ratio of 4.10 and a beta of 1.41.

Analyst Ratings Changes

Several brokerages have recently issued reports on DOCS. The Goldman Sachs Group boosted their price objective on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and upped their price target for the company from $31.00 to $78.00 in a research report on Friday, February 7th. KeyCorp decreased their target price on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Leerink Partners raised Doximity from a "market perform" rating to an "outperform" rating and raised their price objective for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Finally, Needham & Company LLC raised their price objective on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Doximity has an average rating of "Moderate Buy" and a consensus target price of $65.39.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.